FY2029 Earnings Forecast for ELEV Issued By Wedbush
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Analysts at Wedbush issued their FY2029 earnings per share estimates for Elevation Oncology in a research report issued to clients and investors on Friday, March 7th. Wedbush analyst R. Driscoll expects that the company will earn $0.07 per share for the year. The consensus estimate for Elevation […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Analysts at Wedbush issued their FY2029 earnings per share estimates for Elevation Oncology in a research report issued to clients and investors on Friday, March 7th. Wedbush analyst R. Driscoll expects that the company will earn $0.07 per share for the year. The consensus estimate for Elevation […]
